Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

EU bổ sung 130 triệu euro cho sáng kiến UAV giám sát biên giới

EU bổ sung 130 triệu euro cho sáng kiến UAV giám sát biên giới

Thế giới
(Baothanhhoa.vn) - Ủy ban châu Âu (EC) sẽ bổ sung 130 triệu euro cho công nghệ thiết bị bay không người lái (UAV), trong bối cảnh Liên minh châu Âu (EU) đẩy mạnh giám sát biên giới và chuẩn bị tăng cường vai trò của Cơ quan Bảo vệ Biên giới và Bờ biển châu Âu (Frontex).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh